Company / Tangible Book Value per Share
Arrowhead Pharmaceuticals Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$3.75
FY2025
5-year range
$1.73 / $3.99
FY2021-FY2025
Trend
+116.8%
vs FY2024
Sector context
#113 of 209
Health Care
What the data says
At $3.75, Arrowhead Pharmaceuticals's tangible book value per share ranks #113 of 209 in the Health Care sector. Tangible Book Value per Share returned to growth in FY2025 after 4 years of decline, reaching $3.75.
Based on SEC 10-K filings.
3.75 in FY2025 with a 5-year CAGR of -5.0%.
Improved from $2.56 to $3.75 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -0.6%
- 5-Year CAGR
- -5.0%
- 10-Year CAGR
- -
Sector benchmark
#113 of 209 in Health CareTop 54% of 209This company $3.75 Sector average $93.47
▼
-96.0% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 116.8% year-over-year.
- Ranks #113 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2020.
- Lowest tangible book value per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.75 | +116.8% |
| FY2024 | $1.73 | -32.5% |
| FY2023 | $2.56 | -33.0% |
| FY2022 | $3.82 | -4.3% |
| FY2021 | $3.99 | -17.4% |
| FY2020 | $4.84 | +75.0% |
| FY2019 | $2.76 | +115.7% |
| FY2018 | $1.28 | +9.7% |
| FY2017 | $1.17 | -27.3% |
| FY2016 | $1.61 | -20.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026